Literature DB >> 13461260

Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors.

R SCHNECKLOTH, I H PAGE, F DEL GRECO, A C CORCORAN.   

Abstract

Entities:  

Keywords:  MALIGNANT CARCINOID SYNDROME/physiology; SEROTONIN/antagonists

Mesh:

Substances:

Year:  1957        PMID: 13461260     DOI: 10.1161/01.cir.16.4.523

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Serotonin and the carcinoid syndrome.

Authors:  W P JONES
Journal:  Can Anaesth Soc J       Date:  1959-04

2.  Carcinoid heart disease.

Authors:  J COSH; J E CATES; D W PUGH
Journal:  Br Heart J       Date:  1959-07

3.  [On the substance liberated in anaphylactic and allergic reaction].

Authors:  G ENGELHARDT; U SCHWABE
Journal:  Klin Wochenschr       Date:  1960-02-15

4.  Serotonin release from carcinoid tumours.

Authors:  W P JONES
Journal:  Can Anaesth Soc J       Date:  1962-01

5.  Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.

Authors:  J P Green; C L Johnson; H Weinstein; S Maayani
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  Clinical and biochemical effects of parachlorophenylalanine in a patient with the carcinoid syndrome.

Authors:  N D Bax; A J Boulton; H F Woods; A R Green
Journal:  Postgrad Med J       Date:  1982-08       Impact factor: 2.401

7.  The malignant carcinoid syndrome. Report of 5 cases.

Authors:  R J Gailitis
Journal:  Am J Dig Dis       Date:  1966-08

8.  Study of the Role of 5-Hydroxytryptamine (Serotonin) and Histamine in the Pathogenesis of Pulmonary Embolism in Man.

Authors:  H H Stone; P Nemir
Journal:  Ann Surg       Date:  1960-11       Impact factor: 12.969

9.  The urinary excretion of 5-hydroxyndoleacetic acid in patients with menopausal flushing.

Authors:  N R ROWELL; J W SUMMERSCALES
Journal:  J Clin Pathol       Date:  1960-11       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.